Building bridges: pharmacists reaching out to help their communities
In this episode of The PJ Pod, two pharmacists tell us how their outreach work is helping to support people’s health needs.…
News
See all-
Alternative to injections for people with severe migraines approved for use on NHS
-
Government to change law to reclassify so-called ‘diet drug’ as a poison
-
Government advisers recommend autumn COVID-19 boosters for people at most risk
-
Pharmacies in England’s most deprived areas provide 50% more NHS services to their local populations
-
UK government rejects proposals for a national formulary for HRT
Sign in now if you’re an RPS member or subscriber.
Become a member of the RPS or subscribe to gain unlimited access.
News from Wales
Alternative to injections for people with severe migraines approved for use on NHS
Government to change law to reclassify so-called ‘diet drug’ as a poison
Should all adults be considered for statin therapy?
First electronic prescriptions in Wales to be sent from GPs to pharmacies by autumn 2023
Almost half of pharmacists have experienced abuse in the past six months, finds RPS survey
Inhaler recycling scheme launched in South Wales after successful trial
Increase in overseas pharmacists applying to train to work in Great Britain
News from Scotland
Government to change law to reclassify so-called ‘diet drug’ as a poison
Almost half of pharmacists have experienced abuse in the past six months, finds RPS survey
Increase in overseas pharmacists applying to train to work in Great Britain
Pharmacies should collect workforce disability data, concludes Scottish pharmacy roundtable
NHS staff offered 7.5% average pay rise in Scotland
Scottish epilepsy medicines registry to deliver data by end of 2022
Hospital pharmacists encouraged to reject ‘insulting’ government pay offer
Genomics
Should we be genetic testing before prescribing analgesics?
Infographic: 2022 unwrapped
Sir Munir Pirmohamed: ‘Now is the time to implement pharmacogenomic testing into the NHS’
Government-funded research to screen genomes of 100,000 babies for rare diseases
Adverse drug reactions reduced by nearly one third after genetic testing, major trial results to show
How we set up the UK’s first clopidogrel genomics testing system
Everything you need to know about the NHS genomic medicine service
Learning & CPD
Perimenopause: symptoms and management
Supporting recently qualified hospital pharmacists: advice for the first few years
Switching antidepressants: advice and practicalities
Insulin in practice for people with type 2 diabetes mellitus
Digoxin monitoring and toxicity management
Research, CPD and Learning: 2022 in review
Test yourself: the 2022 CPD and Learning quiz
Gastrointestinal system diseases
See all-
Inflammatory bowel disease: symptoms and diagnosis
-
Inflammatory bowel disease: treatment and management
-
FDA approves two new drugs for irritable bowel syndrome
-
Antihistamine reduces pain in irritable bowel syndrome
-
Optimising therapy for inflammatory bowel disease
-
Management of patients with inflammatory bowel disease: current and future treatments
-
Management of acute upper gastrointestinal bleeding
-
Understanding irritable bowel syndrome: bugs, brains and leaky barriers
Want to see content related to your country or pharmacy sector on your homepage? Visit your preference centre to update your interests and help us improve your digital experience.
Newly registered?
Find our dedicated career advice and resources, clinical CPD and professional skills content here.
Research
See all-
Making the case for pharmacogenomics in the management of mental health conditions
-
Overview of cancer treatment-related cardiovascular toxicity
-
Errors and the inappropriate use of medicines in UK care homes
-
Clinical impact of CFTR modulator therapy roll-out
-
Should menopause management differ between ethnic groups?
-
The role of circulating tumour DNA in guiding cancer treatment and future applications